Sirius Therapeutics Files for Hong Kong IPO

Source: Cailian Press

[Hong Kong IPO: Sirius Therapeutics Submits Listing Application to HKEX] According to财联社March 31st report, Liffe Securities shows that Sirius Therapeutics has submitted its listing application to the Hong Kong Stock Exchange. The joint sponsors are Goldman Sachs Group, Haitong International, and HSBC.